JP Morgan increased its stake in Dongfeng Group (00489) by approximately 16.71 million shares, with a price of approximately HKD 3.31 per share.
On November 12th, Citic Securities increased its holdings in Dongfeng Group (00489) by 16,712,471 shares, with each share priced at HK$3.3068, for a total amount of approximately HK$55.2648 million.
According to the latest data from the Hong Kong Stock Exchange, on November 12th, JP Morgan increased its holdings in DONGFENG GROUP (00489) by 16,712,471 shares at a price of 3.3068 Hong Kong dollars per share, with a total amount of approximately 552.648 million Hong Kong dollars. After the increase, the latest total holding is approximately 130 million shares, with a latest holding percentage of 5.21%.
Related Articles
HK Stock Market Move | JINGCHENG MAC (00187) increased by over 5%, affiliated with Beijing Bawei to support the world's first tower-type solar thermal replacement project for ultra-heavy oil extraction being put into operation.
Innovative drug blockbuster! Arvinas (ARVN.US) collaborates with Pfizer Inc. (PFE.US) to advance the third-party commercialization of "breast cancer ER degrader."
BOCOM INTL: Slight differences between domestic and foreign capital in the industry fluctuations, seizing the opportunity to layout the undervalued high-quality assets in the innovative pharmaceutical industry chain.
HK Stock Market Move | JINGCHENG MAC (00187) increased by over 5%, affiliated with Beijing Bawei to support the world's first tower-type solar thermal replacement project for ultra-heavy oil extraction being put into operation.
Innovative drug blockbuster! Arvinas (ARVN.US) collaborates with Pfizer Inc. (PFE.US) to advance the third-party commercialization of "breast cancer ER degrader."
BOCOM INTL: Slight differences between domestic and foreign capital in the industry fluctuations, seizing the opportunity to layout the undervalued high-quality assets in the innovative pharmaceutical industry chain.
